Related Experiment Videos
Cost-effectiveness of reduction mammaplasty
Andrew J Taylor1, David Tate, Yvonne Brandberg
1University of Hull, Hull, UK.
International Journal of Technology Assessment in Health Care
|September 28, 2004
Summary
Reduction mammaplasty (RM) is a cost-effective surgical intervention for women with heavy breasts (macromastia or breast hypertrophy). The analysis indicates strong evidence supporting funding for this procedure.
Area of Science:
- Plastic Surgery
- Health Economics
- Quality of Life Research
Background:
- Macromastia or breast hypertrophy (BH) significantly impacts women's quality of life.
- Reduction mammaplasty (RM) is a surgical option for managing heavy breasts.
- Evaluating the cost-effectiveness of RM is crucial for healthcare policy decisions.
Purpose of the Study:
- To compare the benefits of reduction mammaplasty (RM) for women with macromastia/breast hypertrophy (BH).
- To assess the cost-effectiveness of RM within publicly financed healthcare systems.
- To provide evidence for decision-makers regarding RM funding.
Main Methods:
- Re-analysis of existing Swedish outcomes study data.
- Derivation of quality of life measures.
- Calculation of cost per quality-adjusted life year (QALY).
Main Results:
- Reduction mammaplasty (RM) demonstrates a low cost per QALY.
- The findings suggest RM is cost-effective compared to other common interventions.
- The study provides quantitative evidence of RM's value.
Conclusions:
- Strong evidence supports funding for reduction mammaplasty (RM).
- Healthcare decision-makers should review current policies based on this evidence.
- RM is a valuable intervention for women with macromastia/BH.